negative symptoms phenotype
Evidence from:
primary |
all sources
Related entities (24)
Mentioned in (22)
Papers in which this entity is mentioned.
- Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users. (2023)
- Peripheral Biomarkers for First-Episode Psychosis-Opportunities from the Neuroinflammatory Hypothesis of Schizophrenia. (2019)
- Sex differences in the developing brain: insights from multimodal neuroimaging. (2019)
- Epigenetic mechanisms in alcohol- and adversity-induced developmental origins of neurobehavioral functioning. (2018)
- Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. (2018)
- Cerebral organoids reveal early cortical maldevelopment in schizophrenia-computational anatomy and genomics, role of FGFR1. (2017)
- Social cognition as an RDoC domain. (2016)
- Hypomania after augmenting venlafaxine and olanzapine with sarcosine in a patient with schizophrenia: a case study. (2015)
- Time to First Morning Cigarette and Risk of Chronic Obstructive Pulmonary Disease: Smokers in the PLCO Cancer Screening Trial. (2015)
- The impact of environmental factors in severe psychiatric disorders. (2014)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012)
- Pubertal stage and brain anatomy in girls. (2012)
- Exploration and modulation of brain network interactions with noninvasive brain stimulation in combination with neuroimaging. (2012)
- MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. (2011)
- The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: the UCLA family study. (2010)
- MR diffusion tensor imaging: a window into white matter integrity of the working brain. (2010)
- Reduced intra-amygdala activity to positively valenced faces in adolescent schizophrenia offspring. (2010)
- Corpus callosum abnormalities and their association with psychotic symptoms in patients with schizophrenia. (2010)
- Cannabis and psychosis/schizophrenia: human studies. (2009)
- On the value of homogeneous constructs for construct validation, theory testing, and the description of psychopathology. (2009)
- Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. (2008)
- Genetic and environmental factors in complex neurodevelopmental disorders. (2007)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| negative symptoms | phenotype | 22 | 47 |
| affective flattening | phenotype | 1 | 2 |
| amotivation | phenotype | — | — |